Discovery of novel VEGFR-2 inhibitors. Part II: Biphenyl urea incorporated with salicylaldoxime

被引:40
|
作者
Gao, Hongping [1 ]
Su, Ping [1 ]
Shi, Yaling [1 ]
Shen, Xiuxiu [1 ]
Zhang, Yanmin [1 ]
Dong, Jinyun [1 ]
Zhang, Jie [1 ]
机构
[1] Xi An Jiao Tong Univ, Sch Pharm, Hlth Sci Ctr, Xian 710061, Shaanxi Provinc, Peoples R China
基金
中国国家自然科学基金;
关键词
VEGFR-2; Biphenyl urea; Intramolecular hydrogen bond; Salicylaldoxime; RECEPTOR TYROSINE KINASE; BIOLOGICAL EVALUATION; ACID-DERIVATIVES; CANCER-CELLS; GROWTH; EGFR; ANGIOGENESIS; POTENT; AGENTS;
D O I
10.1016/j.ejmech.2014.11.032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel VEGFR-2 inhibitors containing oxime as hinge binding fragment were described. A strategy of pseudo six-membered ring formed through intramolecular hydrogen bond was employed to mimic the planar quinazoline. The oxime group was firstly introduced to interact with hinge region of VEGFR-2. Most of compounds tested showed moderate to high VEGFR-2 inhibitory activity. In particular, 121, 12p and 12y exhibited significant enzymatic inhibitory activity as well as potent antiproliferative activity against cancer cells. Molecular docking suggested that the salicylaldoxime formed two hydrogen bonds with hinge region. These biphenylureas could serve as promising lead compounds for developing novel anticancer agents. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:232 / 240
页数:9
相关论文
共 50 条
  • [1] Discovery of biphenyl-aryl ureas as novel VEGFR-2 inhibitors. Part 4: Exploration of diverse hinge-binding fragments
    Su, Ping
    Wang, Jinfeng
    Shi, Yaling
    Pan, Xiaoyan
    Shao, Ruili
    Zhang, Jie
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) : 3228 - 3236
  • [2] Design, synthesis and biological evaluation of biphenyl urea derivatives as novel VEGFR-2 inhibitors
    Wang, Chen
    Dong, Jinyun
    Zhang, Yanmin
    Wang, Fang
    Gao, Hongping
    Li, Pengfei
    Wang, Sicen
    Zhang, Jie
    MEDCHEMCOMM, 2013, 4 (11) : 1434 - 1438
  • [3] Discovery of biphenyl-based VEGFR-2 inhibitors. Part 3: Design, synthesis and 3D-QSAR studies
    Lu, Wen
    Li, Pengfei
    Shan, Yuanyuan
    Su, Ping
    Wang, Jinfeng
    Shi, Yaling
    Zhang, Jie
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (05) : 1044 - 1054
  • [4] 2-Cyanopyridines as novel VEGFR-2 / VEGFR-3 inhibitors. Part 1. Discovery and SAR of 2-Cyanopyridines
    Scott, William J.
    Adnane, Lila
    Phillips, Barton
    Chen, Yuanwei
    Dixon, Julie A.
    Dumas, Jacques
    Lee, Wendy
    Burke, Jennifer
    Chandler, Brent
    Chen, Jianqing
    Chen, Zhi
    Fan, Jianmei
    Jones, Ben
    Raudenbusch, Brian
    Redman, Aniko
    Shao, Jianxing
    Yi, Lin
    Zhu, Qingming
    Cao, Yichen
    Ichetovkin, Marina
    Noell, Steve
    Hofilena, Gloria
    CANCER RESEARCH, 2006, 66 (08)
  • [5] 4-Aminopyrimidine-5-carbaldehyde oximes as potent VEGFR-2 inhibitors. Part II
    Huang, Shenlin
    Li, Ronghua
    LaMontagne, Kenneth R.
    Greenberger, Lee M.
    Connolly, Peter J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1815 - 1818
  • [6] Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: Design, synthesis and biological evaluation
    Wang, Chen
    Gao, Hongping
    Dong, Jinyun
    Zhang, Yanmin
    Su, Ping
    Shi, Yaling
    Zhang, Jie
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (01) : 277 - 284
  • [7] Development of thienopyridines as VEGFR-2 kinase inhibitors.
    Munchhof, MJ
    Adams, MA
    Atherton, JA
    Beebe, JS
    Casavant, JC
    Cooper, BC
    Doty, JD
    Emerson, EE
    Foster, BF
    Gant, TG
    Garshasb, SG
    Goodwin, PG
    Harriman, SH
    Higdon, CH
    Hillerman, SH
    Interi, CI
    Jani, JJ
    Knauth, LK
    Marx, MM
    Natarajan, VN
    Noe, MN
    Rossi, AR
    Savage, DS
    Shaeffer, TS
    Smolarek, TS
    Snow, SS
    Sobolov, SS
    Soderstrom, ES
    Sun, JS
    Turncliff, RT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U197 - U197
  • [8] 2-Cyanopyridines as novel VEGFR-2 / VEGFR-3 inhibitors. Part 2. Inhibition of tumor growth and metastasis by a cyanopyridine
    Adnane, Lila
    Scott, William J.
    Adams, Paul
    Li, Volkhart
    Wilhelm, Scott M.
    Hofilena, Gloria
    Ichetovkin, Marina
    Lantz, Lori
    Lyga, Andrew
    Wilkie, Dean
    Noell, Stephen
    Cao, Yichen
    Lee, Wendy
    Raudenbush, Brian
    Carter, Christopher
    Trail, Pamela A.
    Bull, Cathy
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Discovery, synthesis, SAR, and in vitro/in vivo characterization of a novel quinolinone class of VEGFR-2 (KDR) kinase inhibitors.
    Fraley, ME
    Antanavage, J
    Arrington, KL
    Ciecko, PA
    Coll, KE
    Gibbs, JB
    Hambaugh, SR
    Hartman, GD
    Heimbrook, DC
    Hoffman, WF
    Hungate, RW
    Kohl, NE
    Mao, XZ
    McFall, RC
    Rands, E
    Rickert, K
    Sepp-Lorenzino, L
    Shipman, JM
    Tebben, AJ
    Thomas, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U44 - U45
  • [10] Discovery of novel VEGFR-2 inhibitors. Part 5: Exploration of diverse hinge-binding fragments via core-refining approach
    Shan, Yuanyuan
    Gao, Hongping
    Shao, Xiaowei
    Wang, Jinfeng
    Pan, Xiaoyan
    Zhang, Jie
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 103 : 80 - 90